Minerva Neurosciences, Inc.
NERVPharmaceutical Preparations · SIC 2834 · CIK 0001598646
Revenue FY2025
—
Net Income
$(293.0M)
EPS (Basic)
$-34.67
Net Margin
—
ROE
208.5%
Total Equity
$(141.0M)
Shares Out
48M
Minerva Neurosciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Vivo Capital
Vivo Capital
$24.0M
0.4%
—
Adage Capital Management
Adage Capital Management
$7.9M
0.0%
—
Insider Transactions
Reading stored insider transactions…